ABSTRACT: The effect of ascorbic acid on natural killer (NK) cells in the marine toad Bufo marinus has been analyzed in vitro and in vivo. Peripheral blood leukocytes (PBL) which were pre-incubated with ascorbic acid for 1 h at different concentrations (1 X lo3, 1 X 104 and 1 X 105 M), exhibited a significant inhibition of NK cell activity (31.8 to 77.3 %). Similarly, injection of ascorbic acid into the dorsal lymph sac of toads at 10 mg kg-' d-' inhibited NK cell activity; 16
INTRODUCTION
and metastasis. To determine a possible influence of vitamin C on amphibian NK cells, we analyzed the The antiturnor activity of ascorbic acid (vitamin C) effects of ascorbic acid on toad NK cell activity both in has been examined by several investigators, for examvitro and in vivo. ple Pauling (1980) found that vitamin C inhibits growth of tumors. In other analyses ascorbic acid inhibited the MATERIAL AND METHODS appearance of dimethylbenzanthracene (DMBA) induced papillomas of the skin of toads Bufo regularis Toads. We used Bufo marinus of both sexes, purand also caused regression of established papillomas chased from St. Croix Biological, Stillwater, Minnesota, (Sadek & Abdelmeguid 1982) . Amphibians have a well USA. They were kept in plastic pans with water which developed immune system that consists of major celluwas changed twice weekly. They were fed meal worms lar and humoral components (Cooper 1976 (Ghoneum & Cooper 1987 ) and the tubes. The buffy coat was carefully removed and tumor cell line YAC-1 (a T cell lymphoma of mouse washed twice in Amphibian Ringer Solution (ARS) origin) (Ghoneum et al. 1990) . NK cells are considered (Ghoneum & Cooper 1987) . to be a possible first line of defense in antitumor Target cells. The YAC-1 tumor cell line (a Maloney immunosurveillance (Herberman 1982, Ghoneum et al. leukemia virus-induced mouse T-cell lyrnphoma of A/ 1987).
Sn mouse origin) was maintained in our laboratory in Factors enhancing NK cell activity could thus be complete medium (CM) consisting of RPMI-1640, suprelevant to enhancement of resistance to tumor growth plemented with 1 % antibiotics (100 U penicillin and 100 pg ml-' streptomycin). Ascorbic acid. Ascorbic acid was purchased from Montreux, Switzerland, March 5-8, 1989 For in vitro studies, ascorbic acid was dissolved in ' ' Addressee for correspondence phosphate buffered saline (PBS) and adjusted at con- Org. 9: 1-4, 1990 centrations of 10-3 to M. PBL were incubated with ascorbic acid for 1 h at room temperature then washed twice with ARS. For in vivo experiments, toads were injected with vitamin C into the dorsal lymph sac at a dose of l 0 mg kg-' d-l, and NK cell activity was examined at 1 and 3 tvk post-treatment.
Cytotoxic assay. YAC-1 target cells (5 x 106) were labeled with 100 pCi sodium chromate solution (New England Nuclear, Boston, Massachusetts, USA) for l h and washed 4 times in 5 m1 Hanks' balanced salt solution (HBSS) as previously described . Target cells ( l X 104) in 0.1 m1 CM were pipetted into 96 well-round bottom Linbro plates. Effector cells were suspended at 10 X 106 ml-' ARS, and pipetted into quadruplicate wells to give effector:target (E:T) cell ratios of 25: i , 50: i drid i O O : i . Following incubation for 4 h at room temperature, plates were centrifuged at 400 X g for 5 min and 0.1 m1 supernatant from each well collected and counted in triplicate in a Gamma counter. The percentage of isotope released was calculated using the following formula:
experimental release -spontaneous release % Lysis = X 100 maximum release -spontaneous release Spontaneous release from target cells was always 8 to 10 O/ O of total release; maximum release was measured by adding 0.1 m1 Triton X100; all values in counts min-l. Conjugate formation. The method previously described by Kumagai et al. (1982) was followed. In brief, PBL (1 X lo5) were incubated with YAC-1 target cells (1 X 106) in 1 m1 of ARS in 12 X 75 mm glass tubes, sedimented by centrifugation at 130 X g for 5 min and incubated for 1 h at 4 "C. Pellets were resuspended and cytocentrifuged smears stained with Giemsa. The percent of conjugates was examined by counting 200 lymphocytes (bound and free) in triplicate samples.
Lytic units (LU). LUs were calculated from effector titration curves according to our previously demonstrated procedure . One LU was defined as the number of effector cells required to achieve 10 % lysis; LU X is the number of LUs in 10 million effector cells.
Statistical analysis. A 2-tailed Student's t-test was used to determine the significance of difference between different experimental groups at p < 0.05.
RESULTS
In vitro effects PBL which were preincubated with ascorbic acid for l h inhibited NK cell activity in a dose response relationship: 77.3 % at 1 x lo3; 63.4 ' 1 0 at 1 x 104 and 31.8% at 1 X lo5 M ascorbic acid (Table 1 ). This inhibitory effect was detected at all effector leukocyte target ratios, 25: 1, 50: 1 and 100: 1. Further experiments were conducted to examine the effect of vitamin C on the binding capacity of NK cells to their target tumor cells. In vivo effects Data in Table 2 demonstrated that vitamin C inhibits NK cell activity in a time-dependent manner. NK cell activity was inhibited (16.1 9/0) at Week 1 and had decreased further, to 25.8% by Week 3, when com- f 2.5 f 3.9 3 2.4 7.8 13.8 16.1 25.8 2 1.2 t 2.9 f 2.9 pared to controls. Inhibition of NK cell activity was not correlated with changes in the percent of conjugate formation between effector cells and YAC-1 tumor cells. The percent of conjugates was nearly the same in treated and nontreated groups (Fig. 1B) .
DISCUSSION
Ascorbic acid ~nhibited toad Bufo marinus NK cell activity in vivo and in vitro, which agrees with findings using human NK cells (Huwyler et al. 1985) . The mechanism by which vitamin C affects NK activity is not fully understood, but could be attributed to the quick reaction of vitamin C with hydroxyl radicals (Anbar & Neta 1967) and oxygen radicals (Nishikimi 1976) , where it is oxidized to hydroascorbate. These hydroxyl radical scavengers have an inhibitory function against NK activity (Sythanthiran et al. 1984) . Further studies by Huwyler et al. (1985) , demonstrated suppression in activity of NK cells after culturing them with vitamin C at 37"C, whereas NK cells incubated with vitamin C a t 4 "C exhibited normal activity. Therefore, ascorbic acid may act as a radical scavenger on NK cells thus suppressing their cytotoxic reactivity without interfering with the binding capacity (of these effectors) to tumor target cells. The effect of vitamin C seems to be cytostatic and not cytotoxic, since trypanblue exclusion-test demonstrated that vitamin C did not affect the viability of PBL.
The inhibitory effect of vitamin C could also be attributed to its ability to increase the production of Prostaglandin E2 (PGE2) which is known to inhibit NK activity (Siegel & Morton 1984) . In contrast, other studies demonstrated an immune modulatory effect of vitamin C as manifested by activation of T cell-mediated immunity and enhancement of interferon (IFN) production, which would not include alterations in NK activity (Siegel & Morton 1983) . The reason for such controversy is unknown, but may be attributed to differences in animal models and the way of administering vitamin C -while Siegel & Morton (1984) mixed vitamin C with the drinking water of mice, we injected vitamin C into the dorsal lymph sac of toads. Or, it could b e due to the source of NK cells, i.e. murine spleen vs amphibian PBL.
Previous studies demonstrated that ascorbic acid caused regression of skin papillomas in the Egyptian toad Bufo regularis (Sadek & Abdelmequid 1982) .
According to a n earlier study by Siege1 (1975) , vitamin C may protect against some viral infections by enhancing IFN production. It is well-known that IFN exerts anticancer activity in experimental animals (Balkwill 1985) . Such conflicting reports make the mechanism of antitumor activity of ascorbic acid more complicated. Since NK cell activity is augmented by IFN, ascorbic acid may exert its effect via several unknown interactions. Much additional study is required to understand the mechanism(s) of action of ascorbic acid on cell mediated immune (CMI) function and its relationship to immune-surveillance.
